Capital Partnerships Planning For Long-Term Success
Source: Almac Group
With significant capital investment in equipment and extensive associated facility modifications, Almac successfully transferred and scaled-up Ironwood Pharmaceuticals’ innovative yet challenging orally delivered peptide product, linaclotide, helping them prepare to meet global demand in multiple territories.
VIEW THE CASE STUDY!
Log In
Signing up provides unlimited access to:
Free Sign Up
Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Pharmaceutical Online? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
This website uses cookies to ensure you get the best experience on our website. Learn more